KSE-listed pharmaceutical firms showing strong 3-quarter results

Published: 2004-11-17 07:00:00

Updated: 2004-11-17 07:00:00

KSE (Korea Stock Exchange)-listed pharmaceutical firms in the first nine months of this year continued to post robust sales of 2.4 trillion won, up 14.5 percent compared with 2.1 trillion won from a year earlier, according data released by Yakup Shinmoon.

The data showed that except for Jeil, Ilsung, Korea Green Cross, Dongsung and Hanall, sales by the 21 pharmaceutical firms enjoyed t...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.